Aim of the pillar 

Ensure that the rights and safety of stem cell donors are promoted and protected.

 Overview of leadership of the pillar can be found here.

What are the positive changes we expect to see as a result of our activities, which will contribute to our intended impact?
  • Lessons learnt from adverse events and reactions (SPEARs) inform donor care standards and practices and are reflected in the WMDA Standards.
  • A rapid alert system for disseminating information on serious adverse events and reactions to all members of the international community in contact with allogeneic donors and patients.

  • Globally harmonised medical assessment criteria simultaneously protect the interest of donors whilst ensuring the safety of cellular products across international boundaries.
  • International resource on all medical and ethical issues pertaining to stem cell donation, donor safety, donor outcome and the impact of donor factors on patient outcome.
  • Donor protection and safety standards are aligned with developments in novel cellular therapies. 
  • The experiences and needs of donors are understood, communicated and reflected in donor care standards.
  • WMDA is recognised as a global advocate for donor care.
  • WMDA members adopt standards, protocols and procedures that safeguard the rights and safety of donors.
  • National and international authorities support stem cell donation and recognise donor care standards.  
What will WMDA and its members do?
  • Update and promote donor care standards that reflect evidence, best practice and ethical considerations.
    Example: develop and maintain guidelines in relation to donor consent/counselling
  • Collect, analyse and report data relating to adverse events and reactions and share insight with members and regulatory authorities. 
    Example: develop and maintain the SPEAR reporting tool for both related and unrelated adverse events and reactions
  • Improve, maintain and promote WMDA’s Donor Medical Suitability Wiki
    Example: respond to emerging infectious diseases outbreaks (e.g. Zika); expand Wiki to include the screening of cord blood donors.
  • Help WMDA members to inform and influence national and international authorities and other stakeholders (e.g. WBMT, EBMT), so that voluntary stem cell donation and donor care is supported.
  • Explore the role of WMDA in novel therapies and the future role of volunteer donors.
    Example: develop ethical principles and guidelines and tools for registries and partners involved in cellular therapy.

  • No labels